novemb
januari
case
unusu
sever
atyp
pneumonia
observ
guangdong
provinc
china
diseas
character
lack
respons
convent
antibiot
therapi
occurr
cluster
case
within
famili
healthcar
set
retrospect
first
known
case
diseas
later
call
sever
acut
respiratori
syndrom
sar
januari
number
case
unusu
atyp
pneumonia
continu
increas
exampl
superspread
incid
punctuat
cours
subsequ
sar
epidem
novemb
februari
case
identifi
onethird
healthcar
worker
tabl
februari
doctor
work
hospit
citi
guangzhou
provinci
capit
guangdong
arriv
hong
kong
check
hotel
treat
patient
atyp
pneumonia
guangzhou
ill
sinc
februari
stay
ninth
floor
hotel
led
infect
least
guest
visitor
travel
hanoi
toronto
vancouv
singapor
usa
philippin
guangzhou
australia
five
secondari
case
initi
cluster
infect
hanoi
singapor
toronto
two
cluster
infect
within
hong
kong
signific
singl
event
global
spread
sar
arguabl
dramat
known
event
global
spread
infecti
diseas
howev
secondari
case
larg
dispers
outsid
hong
kong
cluster
case
remain
invis
epidemiolog
linkag
reconstruct
midmarch
februari
march
diseas
outbreak
recogn
hanoifrench
hospit
vietnam
princ
wale
hospit
hong
kong
dr
carlo
urbani
world
health
organ
communic
diseas
expert
station
vietnam
examin
first
case
diseas
outbreak
hanoi
provid
first
case
descript
new
diseas
later
dr
urbani
one
victim
succumb
diseas
march
issu
global
health
alert
regard
atyp
pneumonia
particular
risk
healthcar
worker
subsequ
singapor
toronto
also
report
cluster
case
march
issu
travel
advisori
new
diseas
name
sar
preliminari
case
definit
provid
set
virtual
network
virologist
clinician
epidemiologist
rapidli
collat
evalu
dissemin
inform
new
diseas
within
week
sar
spread
affect
patient
countri
across
five
contin
fatal
overal
casefat
rate
healthcar
facil
serv
major
amplifi
infect
constitut
report
case
march
etiolog
agent
sar
identifi
novel
coronaviru
subsequ
term
sar
coronaviru
sar
cov
serolog
test
demonstr
human
popul
prior
evid
infect
sar
cov
indic
viru
newli
emerg
human
impli
like
zoonot
origin
earli
case
detect
isol
infect
individu
reduc
interrupt
sar
cov
transmiss
across
world
juli
announc
chain
human
transmiss
sar
broken
outbreak
end
inde
histor
triumph
global
public
health
although
sar
subsequ
reemerg
caus
limit
human
diseas
one
instanc
limit
humantohuman
transmiss
result
laboratori
escap
zoonot
transmiss
live
game
anim
market
guangdong
decemb
tabl
human
outbreak
sar
control
sar
coronaviru
member
genu
coronaviru
within
famili
coronavirida
order
nidoviral
coronavirus
classifi
genet
antigen
characterist
three
group
sar
cov
present
regard
group
coronaviru
envelop
positivesens
singlestrand
rna
viru
genom
size
approx
kbp
viru
particl
approxim
nm
diamet
distinct
corona
petalshap
spike
surfac
compris
spike
glycoprotein
protein
trimer
form
viral
surfac
ntermin
variabl
subdomain
contain
motif
respons
receptor
bind
conserv
subdomain
contain
heptad
repeat
coiledcoil
structur
import
membran
fusion
process
subdomain
remain
noncleav
form
intact
sar
cov
virion
cleavag
believ
occur
within
endocyt
vesicl
viral
entri
process
envelop
also
contain
transmembran
glycoprotein
much
smaller
amount
envelop
e
protein
protein
triplespan
membran
protein
key
role
coronaviru
assembl
hemagglutininesteras
glycoprotein
found
group
coronavirus
absent
sar
cov
nucleocapsid
protein
n
interact
viral
genom
rna
form
viral
nucleocapsid
viral
replic
complex
believ
local
within
doublemembran
vesicl
autophagosom
genom
sar
cov
typic
coronaviru
viral
genom
rna
least
open
read
frame
orf
figur
genom
code
nonstructur
protein
structur
protein
accessori
protein
genom
rna
encod
replicas
gene
function
mrna
gener
polyprotein
translat
direct
ribosom
frameshift
rf
signal
contain
nucleotid
slipperi
sequenc
rna
pseudoknot
contrast
structur
accessori
protein
product
deriv
subgenom
rna
sgrna
synthes
discontinu
rna
transcript
translat
product
e
n
viral
structur
protein
describ
recent
report
protein
encod
abl
interact
contain
ion
channel
activ
also
structur
protein
howev
full
function
protein
yet
determin
polyprotein
gener
replicas
gene
cleav
papainlik
proteinas
part
proteinas
gener
nonstructur
protein
figur
b
primerdepend
rnadepend
rna
polymeras
rdrp
wherea
noncanon
rdrp
synthes
primer
util
addit
eight
eight
subunit
abl
form
hexadecam
hollow
cylinderlik
structur
rnabind
studi
overal
architectur
complex
suggest
might
encircl
rna
confer
process
singlestrand
rnabind
protein
abl
interact
helicas
unwind
duplex
rna
dna
direct
shown
adpribos
phosphatas
exonucleas
endoribonucleas
oribos
methyltransferas
activ
respect
four
protein
distantli
relat
cellular
enzym
involv
rna
metabol
observ
may
relev
viral
rna
process
contain
two
zinc
finger
motif
suggest
regul
vrna
synthesi
biolog
function
larg
unknown
report
induc
chemokin
dysregul
host
mrna
degrad
dispens
viru
replic
contain
put
transmembran
domain
apart
orf
encod
replicas
structur
protein
viral
genom
contain
addit
orf
code
accessori
protein
genet
modifi
recombin
virus
without
accessori
orf
shown
replic
compet
cell
cultur
indic
accessori
orf
may
essenti
viru
replic
vitro
howev
recombin
virus
delet
region
attenu
suggest
protein
might
function
import
viral
replic
pathogenesi
vivo
accessori
protein
induc
apoptosi
transfect
cell
also
evid
suggest
protein
incorpor
virion
protein
encod
shown
inhibit
nuclear
import
function
interferon
antagonist
infect
cell
properti
might
relat
viru
virul
interestingli
compar
sequenc
analysi
sar
cov
isol
palm
civet
see
human
show
anim
isol
contain
nt
sequenc
absent
human
isol
obtain
later
phase
sar
outbreak
result
human
sar
cov
encod
protein
wherea
correspond
orf
anim
isol
encod
singl
protein
known
protein
protein
anim
human
differenti
bind
affin
variou
sar
cov
structur
protein
furthermor
express
e
downregul
infect
cell
observ
may
suggest
delet
might
modul
replic
pathogenesi
human
sar
cov
crystal
structur
protein
suggest
might
lipid
bind
protein
function
yet
identifi
overal
accessori
protein
may
play
role
viral
replic
pathogenesi
end
januari
patient
sar
guangdong
handl
kill
sold
wild
anim
prepar
serv
food
howev
risk
factor
found
case
februari
april
viru
adapt
effici
humantohuman
transmiss
thu
earli
epidemiolog
evid
point
live
game
anim
trade
potenti
sourc
sar
cov
sarslik
coronavirus
identifi
number
small
mammalian
speci
sold
live
game
anim
market
guangdong
includ
palm
civet
paguma
larvata
raccoon
dog
nyctereut
procyonid
chines
ferret
badger
melogal
moschata
high
proport
individu
work
market
observ
develop
antibodi
sar
cov
although
none
histori
diseas
virus
isol
reemerg
sar
case
guangdong
decemb
similar
found
civet
market
rather
virus
caus
global
outbreak
earli
observ
strongli
implic
live
game
anim
trade
interfac
interspeci
transmiss
precursor
anim
sarslik
coronaviru
human
sar
cov
shed
week
experiment
infect
palm
civet
mani
speci
appear
clear
viru
rapidli
civet
live
anim
market
often
observ
posit
sarslik
coronaviru
rna
civet
test
farm
suppli
market
caught
wild
rare
evid
infect
thu
palm
civet
believ
like
natur
reservoir
precursor
sar
cov
see
recent
group
coronavirus
relat
sar
cov
identifi
rhinolophu
bat
hong
kong
mainland
china
bat
also
sold
live
game
anim
market
believ
relat
bat
coronavirus
may
precursor
sar
cov
origin
see
phylogeni
sar
cov
sarslik
civet
bat
coronavirus
form
distinct
phylogenet
subgroup
within
group
coronavirus
figur
genet
phylogenet
analysi
indic
virus
associ
earli
phase
human
sar
outbreak
close
relat
virus
found
palm
civet
small
mammal
live
game
anim
market
guangdong
genom
virus
earli
phase
human
outbreak
observ
strong
posit
select
pressur
suggest
viru
rapidli
adapt
new
host
furthermor
viru
civet
also
found
strong
posit
select
pressur
support
view
civet
natur
host
precursor
sarslik
coronaviru
search
precursor
sar
cov
led
discoveri
number
novel
coronavirus
bat
relat
group
group
coronavirus
bat
coronavirus
genet
relat
sar
cov
group
like
direct
indirect
precursor
sar
cov
see
interestingli
consid
overal
recent
discov
group
group
includ
sar
covlik
bat
coronavirus
appear
evolutionari
stasi
mani
mammalian
coronavirus
still
appear
evolutionari
select
pressur
rais
intrigu
possibl
bat
may
fact
precursor
sar
cov
also
mammalian
coronavirus
function
receptor
sar
cov
human
cell
angiotensinconvert
enzym
bind
receptorbind
motif
amino
acid
residu
sar
cov
spike
protein
human
sar
cov
protein
bind
effici
human
civet
civetlik
sar
cov
protein
bind
effici
civet
poorli
human
spike
protein
bat
sarslik
coronaviru
lack
receptorbind
motif
therefor
unlik
bind
human
find
explain
increas
human
transmiss
sar
cov
later
stage
sar
outbreak
observ
human
sar
cov
effici
infect
civet
experiment
condit
failur
civet
sar
cov
bat
sarslik
cov
replic
product
primat
cell
support
replic
human
sar
cov
find
also
explain
poor
virul
transmiss
reemerg
sar
decemb
human
believ
infect
civetlik
sar
cov
cellsurfac
molecul
lsign
dcsignr
dcsign
lsectin
may
serv
bind
receptor
appear
function
viral
receptor
absenc
may
howev
promot
cellmedi
transfer
viru
suscept
target
cell
hand
bind
lsign
appear
lead
proteasomedepend
viral
degrad
may
function
scaveng
receptor
see
transmiss
respiratori
droplet
major
sourc
infecti
viru
transmiss
sar
howev
aerosol
exposur
probabl
contribut
diseas
transmiss
least
defin
instanc
aerosolgener
procedur
eg
nebul
highflow
oxygen
therapi
intub
use
unusu
stabil
sar
cov
also
suggest
contamin
surfac
fomit
may
contribut
diseas
spread
sar
cov
present
fece
urin
possibl
bodi
secret
bodi
fluid
may
also
play
part
diseas
transmiss
largest
singl
outbreak
sar
amoy
garden
apart
block
hong
kong
individu
infect
singl
index
case
believ
caus
aerosol
gener
infect
bodi
secret
eg
fece
estim
incub
period
sar
day
outbreak
major
case
transmit
diseas
patient
account
disproportion
larg
number
secondari
case
host
factor
may
play
role
superspread
event
mani
case
uniqu
combin
host
factor
environment
circumst
facilit
transmiss
contrast
high
transmiss
rate
superspread
event
within
hospit
less
evid
secondari
transmiss
within
famili
within
household
eg
hong
kong
notwithstand
superspread
phenomenon
character
sar
basic
reproduct
number
ro
sar
estim
rang
seroepidemiolog
studi
contact
sar
patient
adult
children
reveal
asymptomat
infect
uncommon
absenc
larg
number
asymptomat
transmitt
pauciti
transmiss
first
day
ill
explain
success
public
health
measur
aggress
case
detect
isol
interrupt
transmiss
humanadapt
sar
cov
control
global
diseas
outbreak
featur
sar
attribut
observ
unlik
mani
acut
viral
respiratori
infect
sar
transmiss
mostli
occur
fifth
day
ill
turn
probabl
relat
low
viral
load
upper
respiratori
tract
earli
phase
ill
see
clinic
featur
sar
pathognomon
contact
histori
virolog
evid
infect
import
confirmatori
diagnosi
sar
typic
start
myalgia
loos
stool
around
time
onset
fever
without
coryza
sore
throat
seen
patient
upper
respiratori
manifest
less
commonli
observ
radiolog
abnorm
observ
case
initi
present
preced
lower
respiratori
tract
symptom
approxim
patient
children
much
milder
ill
adult
mortal
rate
progress
increas
age
patient
particularli
progress
lower
respiratori
tract
involv
wateri
diarrhea
extrapulmonari
manifest
includ
hepat
dysfunct
mark
lymphopenia
involv
b
subset
natur
killer
nk
cell
high
serum
level
chemokin
interleukin
proinflammatori
cytokin
observ
overal
casefat
rate
termin
event
sever
respiratori
failur
associ
acut
respiratori
distress
syndrom
ard
multipl
organ
failur
age
presenc
comorbid
viral
load
nasopharynx
serum
first
day
ill
correl
advers
prognosi
autopsi
find
die
first
day
ill
diffus
alveolar
damag
desquam
pneumocyt
hyalin
membran
format
viral
rna
detect
quantit
polymeras
chain
reaction
pcr
high
copi
number
lung
intestin
lymph
node
lower
level
spleen
liver
kidney
lung
biopsi
tissu
autopsi
tissu
patient
die
first
day
diseas
onset
viral
antigen
viral
nucleic
acid
demonstr
immunohistochemistri
situ
hybrid
method
respect
alveolar
epitheli
cell
lesser
extent
macrophag
unconfirm
studi
also
report
detect
viru
particl
viral
rna
multipl
organ
find
requir
independ
confirm
highli
sensit
specif
realtim
pcr
assay
detect
viral
rna
remain
best
choic
earli
sar
diagnosi
viral
rna
detect
respiratori
specimen
fece
serum
urin
specimen
lower
respiratori
tract
endotrach
aspir
higher
viral
load
upper
respiratori
tract
better
diagnost
clinic
specimen
viral
load
low
first
day
diseas
neg
pcr
result
specimen
collect
time
exclud
diagnosi
test
multipl
specimen
improv
detect
rate
sar
viru
cultur
vero
cell
viral
antigen
detect
test
much
less
sensit
revers
transcriptas
pcr
rtpcr
detect
viru
viral
rna
remain
detect
respiratori
secret
fece
mani
week
onset
ill
specimen
rare
yield
viru
isol
third
week
ill
seroconvers
immunofluores
neutral
occur
second
week
ill
provid
reliabl
retrospect
diagnosi
enzymelink
immunoassay
use
inactiv
whole
viru
recombin
antigen
conveni
altern
serolog
screen
posit
result
must
confirm
specif
immunofluores
neutral
test
primari
mechan
lung
damag
appear
due
infect
type
type
pneumocyt
key
target
cell
viru
type
pneumocyt
import
repair
lung
injuri
infect
cell
potenti
impair
regen
respons
lung
aggrav
respiratori
impair
wherea
mice
defici
nk
b
lymphocyt
display
similar
kinet
viral
replic
normal
mice
infect
mice
defect
signal
pathway
result
prolong
viral
replic
sever
diseas
find
indic
import
innat
immun
respons
control
infect
least
mous
infect
epitheli
cell
macrophag
myeloid
dendrit
cell
fail
induc
type
interferon
respons
although
interferon
respons
gene
activ
viral
protein
express
n
gene
interferon
antagonist
effect
vitro
contrast
macrophag
dendrit
cell
respond
infect
vitro
strong
chemokin
respons
includ
eg
elev
serum
sar
patient
macrophagechemoattract
chemokin
may
explain
predominantli
macrophag
infiltr
lung
evid
viral
replic
within
intestin
epitheli
cell
minim
cellular
infiltr
disrupt
intestin
architectur
pathogenesi
diarrhoea
sar
remain
unclear
sar
emerg
diseas
unknown
etiolog
empir
therapeut
option
initi
test
includ
broad
spectrum
antivir
immunomodul
ribavirin
intraven
immun
globulin
type
interferon
sar
convalesc
plasma
corticosteroid
howev
absenc
control
clinic
trial
conclus
drawn
efficaci
intervent
antisar
cov
activ
vitro
demonstr
sever
therapeut
alreadi
clinic
use
condit
includ
lopinavirnelfinavir
glycyrrhizin
baicalin
reserpin
niclosamid
contradictori
report
vitro
activ
ribavirin
interferon
beta
interferon
alpha
summari
take
account
bioavail
compound
vitro
data
interferon
alpha
leukocyt
interferon
alpha
interferon
beta
nelfinavir
appear
worthi
anim
studi
random
placebocontrol
clinic
trial
sar
return
clinic
trial
lopinavir
mg
ritonavir
mg
oral
everi
h
ad
exist
regimen
ribavirin
corticosteroid
therapi
appear
provid
clinic
benefit
compar
histor
control
howev
lack
concurr
control
make
difficult
draw
conclus
similarli
limit
clinic
trial
patient
use
interferon
treatment
show
trend
toward
improv
radiolog
clinic
outcom
without
achiev
statist
signific
studi
primat
model
demonstr
prophylact
therapeut
benefit
pegyl
recombin
interferon
small
interf
rna
therapi
recent
screen
combinatori
chemic
librari
vitro
identifi
potenti
inhibitor
viral
proteas
helicas
spike
proteinmedi
entri
experiment
sar
cov
infect
lead
viru
replic
number
anim
speci
includ
nonhuman
primat
eg
cynomolg
rhesu
macaqu
african
green
monkey
marmoset
monkey
mice
balbc
golden
syrian
hamster
ferret
cat
develop
patholog
lesion
lung
cynomolg
macaqu
ferret
hamster
marmoset
age
balbc
mice
interestingli
wherea
sar
cov
replic
lung
young
age
month
balbc
mice
age
mice
manifest
clinic
symptom
histolog
evid
lung
patholog
reminisc
diseas
human
children
mild
ill
see
furthermor
anim
model
reproduc
gastrointestin
manifest
ill
ideal
anim
model
understand
sar
pathogenesi
lack
support
viral
replic
without
clinic
diseas
adequ
evalu
efficaci
vaccin
wide
rang
strategi
explor
develop
sar
vaccin
includ
inactiv
whole
viru
vaccin
subunit
vaccin
includ
baculoviru
express
subdomain
complet
trimer
spike
protein
viru
express
mammalian
cell
dna
vaccin
express
fulllength
fragment
n
e
protein
vector
vaccin
base
modifi
vaccinia
ankara
mva
viru
vesicular
stomat
viru
adenovir
vector
carri
n
protein
attenu
parainfluenza
viru
type
vector
vaccin
carri
e
n
protein
neutral
antibodi
respons
appropri
cellmedi
immun
respons
measur
correl
immun
vaccin
evalu
experiment
model
challeng
infecti
sar
cov
trial
hamster
attenu
parainfluenza
viru
type
vaccin
individu
express
sar
cov
e
n
protein
indic
protein
construct
elicit
neutral
antibodi
protect
experiment
challeng
furthermor
passiv
transfer
serum
contain
protein
neutral
antibodi
shown
suffici
induc
protect
immun
mice
conclud
neutral
antibodi
protein
import
correl
protect
receptorbind
determin
subdomain
immunodomin
epitop
critic
determin
viru
neutral
antibodi
enhanc
rather
protect
coronaviru
diseas
felin
infecti
periton
antibodydepend
enhanc
concern
sarsco
vaccin
develop
howev
evid
vaccineenhanc
diseas
observ
date
two
possibl
except
report
modifi
vaccinia
ankara
viru
protein
vaccin
led
hepat
vaccin
ferret
independ
confirm
also
report
protein
antibodi
elicit
subunit
vaccin
enhanc
entri
pseudoparticl
carri
spike
lymphoblasto
cell
line
lack
normal
permiss
infect
howev
challeng
experi
hamster
vaccin
induc
protect
evid
diseas
enhanc
passiv
immun
human
monoclon
antibodi
protein
success
protect
mice
ferret
experiment
challeng
reduc
viral
load
lung
nasopharynx
activ
passiv
immun
studi
evalu
protect
challeng
use
homolog
humanadapt
sar
cov
howev
newli
emerg
sar
outbreak
probabl
aris
anim
reservoir
therefor
import
investig
crossprotect
anim
sarslik
cov
none
civet
bat
sar
cov
yet
success
grown
vitro
crossreact
neutral
antibodi
respons
studi
use
lentivirus
pseudotyp
cov
protein
civet
viru
civetlik
viru
caus
reemerg
sar
human
decemb
human
sar
cov
urbanistrain
isol
major
human
sar
outbreak
virus
pseudotyp
human
urbani
viru
protein
neutral
antibodi
civet
sarslik
viru
pseudotyp
civetlik
protein
neutral
antibodi
human
sar
cov
urbani
contrari
antibodi
urbani
viru
appear
enhanc
infect
pseudotyp
virus
find
appear
reflect
receptor
usag
virus
shown
bind
poorli
human
see
develop
vaccin
prevent
reemerg
sarv
cov
zoonot
reservoir
remain
challeng
like
mani
recent
emerg
infecti
diseas
threaten
human
health
sar
zoonosi
sar
cov
respons
global
outbreak
well
adapt
bind
human
effici
transmit
humantohuman
laboratori
remain
potenti
sourc
infect
virus
occur
februari
laboratori
escap
lead
commun
outbreak
sarslik
coronaviru
found
civet
mammal
live
gameanim
market
close
relat
sar
cov
bind
ineffici
human
receptor
see
consequ
human
infect
civet
sarslik
cov
occur
decemb
humantohuman
transmiss
clinic
diseas
mild
sarslik
coronavirus
found
bat
genet
distinct
sar
cov
bat
sarslik
cov
protein
appear
unabl
bind
human
civet
thu
like
reemerg
viru
capabl
caus
human
diseas
sourc
probabl
requir
extens
adapt
intermedi
host
eg
small
mammal
civet
difficult
assess
likelihood
sar
reemerg
possibl
exclud
rapid
expans
live
gameanim
trade
develop
larg
market
southern
china
hous
divers
wild
domest
anim
speci
probabl
import
facilit
emerg
sar
cov
therefor
possibl
like
ebola
sar
may
reemerg
interv
futur
howev
number
epidemiolog
characterist
sar
see
allow
contain
public
health
intervent
diseas
diagnos
inde
chain
commun
transmiss
aris
laboratori
escap
sar
cov
februari
contain
public
health
measur
commun
transmiss
abort
howev
dynam
transmiss
reemerg
viru
differ
particularli
transmiss
occur
earlier
ill
asymptomat
infect
option
control
ultim
consequ
may
differ
remain
import
therefor
understand
better
ecolog
viral
factor
predispos
interspeci
transmiss
emerg
anim
virus
effici
compet
transmiss
human
attent
direct
toward
adapt
strategi
ecolog
factor
import
determin
interspeci
transmiss
rather
focu
diseas
ie
sar
effort
understand
better
molecular
basi
interspeci
transmiss
led
genesi
sar
cov
help
us
prepar
better
next
emerg
infecti
diseas
challeng
whether
come
sar
cov
avian
influenza
yet
unknown
viru
